{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T02:35:53Z","timestamp":1740105353800,"version":"3.37.3"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100013064","name":"Key Research and Development Program of Jiangxi Province","doi-asserted-by":"publisher","award":["20203BBG73063"],"award-info":[{"award-number":["20203BBG73063"]}],"id":[{"id":"10.13039\/501100013064","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020784","name":"Gannan Medical University","doi-asserted-by":"publisher","award":["QD201910"],"award-info":[{"award-number":["QD201910"]}],"id":[{"id":"10.13039\/501100020784","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017691","name":"Guangxi Key Research and Development Program","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82360701"],"award-info":[{"award-number":["82360701"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022957","name":"Double Thousand Plan of Jiangxi Province","doi-asserted-by":"publisher","award":["jxsq2019101064"],"award-info":[{"award-number":["jxsq2019101064"]}],"id":[{"id":"10.13039\/100022957","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004479","name":"Jiangxi Provincial Natural Science Foundation","doi-asserted-by":"publisher","award":["20212ACB216001"],"award-info":[{"award-number":["20212ACB216001"]}],"id":[{"id":"10.13039\/501100004479","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biochemical and Biophysical Research Communications"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.bbrc.2024.150231","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T11:56:19Z","timestamp":1717674979000},"page":"150231","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Structural basis for the inhibition of the HCoV-NL63 main protease Mpro by X77"],"prefix":"10.1016","volume":"724","author":[{"given":"Jie","family":"Xu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinyao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-5717-0184","authenticated-orcid":false,"given":"Wenwen","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiushan","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jian","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbrc.2024.150231_bib1","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/s41392-020-0190-2","article-title":"Overview of lethal human coronaviruses","volume":"5","author":"Chen","year":"2020","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2024.150231_bib2","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1016\/j.cell.2021.02.013","article-title":"Antivirals with common targets against highly pathogenic viruses","volume":"184","author":"Lu","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.bbrc.2024.150231_bib3","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/nm1024","article-title":"Identification of a new human coronavirus","volume":"10","author":"van der Hoek","year":"2004","journal-title":"Nat. Med."},{"key":"10.1016\/j.bbrc.2024.150231_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1086\/426869","article-title":"Human coronavirus NL63 infection in Canada","volume":"191","author":"Bastien","year":"2005","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.bbrc.2024.150231_bib5","doi-asserted-by":"crossref","first-page":"5990","DOI":"10.1038\/s41467-023-41761-1","article-title":"Previous infection with seasonal coronaviruses does not protect male Syrian hamsters from challenge with SARS-CoV-2","volume":"14","author":"Francis","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150231_bib6","doi-asserted-by":"crossref","first-page":"ofad340","DOI":"10.1093\/ofid\/ofad340","article-title":"Seroepidemiology of the seasonal human coronaviruses NL63, 229E, OC43 and HKU1 in France","volume":"10","author":"De Thoisy","year":"2023","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.bbrc.2024.150231_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmmb.2023.100378","article-title":"Virological profile of upper respiratory tract infections in children under 5 years of age- a cross sectional study in a tertiary care hospital in North India","volume":"44","author":"Agarwal","year":"2023","journal-title":"Indian J. Med. Microbiol."},{"key":"10.1016\/j.bbrc.2024.150231_bib8","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1126\/science.1085658","article-title":"Coronavirus main proteinase (3CLpro) structure: basis for design of anti-SARS drugs","volume":"300","author":"Anand","year":"2003","journal-title":"Science (New York, N.Y.)"},{"key":"10.1016\/j.bbrc.2024.150231_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s41586-020-2223-y","article-title":"Structure of Mpro from SARS-CoV-2 and discovery of its inhibitors","volume":"582","author":"Jin","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150231_bib10","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.3390\/molecules27072281","article-title":"Isolation and in silico SARS-CoV-2 main protease inhibition potential of jusan coumarin, a new dicoumarin from artemisia glauca","volume":"27","author":"Suleimen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2024.150231_bib11","article-title":"Structure of main protease from human coronavirus NL63: insights for wide spectrum anti-coronavirus drug design","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.bbrc.2024.150231_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s43556-023-00134-2","article-title":"Crystal structures of main protease (Mpro) mutants of SARS-CoV-2 variants bound to PF-07304814","volume":"4","author":"Jiang","year":"2023","journal-title":"Molecular biomedicine"},{"key":"10.1016\/j.bbrc.2024.150231_bib13","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.3390\/v14092075","article-title":"Structural basis for the inhibition of coronaviral main proteases by a benzothiazole-based inhibitor","volume":"14","author":"Hu","year":"2022","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2024.150231_bib14","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.36678","article-title":"Nirmatrelvir-ritonavir and COVID-19 mortality and hospitalization among patients with vulnerability to COVID-19 complications","volume":"6","author":"Dormuth","year":"2023","journal-title":"JAMA Netw. Open"},{"key":"10.1016\/j.bbrc.2024.150231_bib15","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1056\/NEJMoa2118542","article-title":"Oral nirmatrelvir for high-risk, nonhospitalized adults with covid-19","volume":"386","author":"Hammond","year":"2022","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.bbrc.2024.150231_bib16","doi-asserted-by":"crossref","first-page":"5779","DOI":"10.1080\/07391102.2020.1792989","article-title":"Computational discovery of small drug-like compounds as potential inhibitors of SARS-CoV-2 main protease","volume":"39","author":"Andrianov","year":"2021","journal-title":"J. Biomol. Struct. Dynam."},{"key":"10.1016\/j.bbrc.2024.150231_bib17","doi-asserted-by":"crossref","first-page":"13204","DOI":"10.1021\/jacs.3c02229","article-title":"Multiscale simulations of the covalent inhibition of the SARS-CoV-2 main protease: four compounds and three reaction mechanisms","volume":"145","author":"Grigorenko","year":"2023","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.bbrc.2024.150231_bib18","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.3390\/v15122295","article-title":"Remdesivir derivative VV116 is a potential broad-spectrum inhibitor of both human and animal coronaviruses","volume":"15","author":"Liu","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.bbrc.2024.150231_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41392-023-01587-1","article-title":"A viral RNA-dependent RNA polymerase inhibitor VV116 broadly inhibits human coronaviruses and has synergistic potency with 3CLpro inhibitor nirmatrelvir","volume":"8","author":"Zhang","year":"2023","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.bbrc.2024.150231_bib20","first-page":"1016","volume":"vol. 31","author":"Lin","year":"2023"},{"key":"10.1016\/j.bbrc.2024.150231_bib21","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1038\/s41467-020-18233-x","article-title":"Both Boceprevir and GC376 efficaciously inhibit SARS-CoV-2 by targeting its main protease","volume":"11","author":"Fu","year":"2020","journal-title":"Nat. Commun."},{"key":"10.1016\/j.bbrc.2024.150231_bib22","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.3390\/molecules27051636","article-title":"Jusanin, a new flavonoid from artemisia commutata with an in silico inhibitory potential against the SARS-CoV-2 main protease","volume":"27","author":"Suleimen","year":"2022","journal-title":"Molecules"},{"key":"10.1016\/j.bbrc.2024.150231_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jksus.2022.101826","article-title":"Identification of bioactive molecules from Triphala (Ayurvedic herbal formulation) as potential inhibitors of SARS-CoV-2 main protease (Mpro) through computational investigations","volume":"34","author":"Rudrapal","year":"2022","journal-title":"J. King Saud Univ. Sci."},{"key":"10.1016\/j.bbrc.2024.150231_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.jmb.2022.167706","article-title":"Structural basis of main proteases of coronavirus bound to drug candidate PF-07304814","volume":"434","author":"Li","year":"2022","journal-title":"J. Mol. Biol."},{"key":"10.1016\/j.bbrc.2024.150231_bib25","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.scib.2020.10.018","article-title":"Crystal structure of SARS-CoV-2 main protease in complex with the natural product inhibitor shikonin illuminates a unique binding mode","volume":"66","author":"Li","year":"2021","journal-title":"Sci. Bull."},{"key":"10.1016\/j.bbrc.2024.150231_bib26","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1021\/acsmedchemlett.1c00299","article-title":"Design and evaluation of bispidine-based SARS-CoV-2 main protease inhibitors","volume":"13","author":"Shcherbakov","year":"2021","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.bbrc.2024.150231_bib27","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/jmv.27376","article-title":"The global epidemic of SARS-CoV-2 variants and their mutational immune escape","volume":"94","author":"Tian","year":"2022","journal-title":"J. Med. Virol."},{"key":"10.1016\/j.bbrc.2024.150231_bib28","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/s41577-021-00592-1","article-title":"Progress of the COVID-19 vaccine effort: viruses, vaccines and variants versus efficacy, effectiveness and escape","volume":"21","author":"Tregoning","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.bbrc.2024.150231_bib29","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1111\/febs.15375","article-title":"A Guide to COVID-19: a global pandemic caused by the novel coronavirus SARS-CoV-2","volume":"287","author":"Atzrodt","year":"2020","journal-title":"FEBS J."},{"key":"10.1016\/j.bbrc.2024.150231_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/s41586-020-2008-3","article-title":"A new coronavirus associated with human respiratory disease in China","volume":"579","author":"Wu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.bbrc.2024.150231_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.bj.2020.05.002","article-title":"Computation screening of narcissoside a glycosyloxyflavone for potential novel coronavirus 2019 (COVID-19) inhibitor","volume":"43","author":"Dubey","year":"2020","journal-title":"Biomed. J."}],"container-title":["Biochemical and Biophysical Research Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24007678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0006291X24007678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T11:08:26Z","timestamp":1719054506000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0006291X24007678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":31,"alternative-id":["S0006291X24007678"],"URL":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150231","relation":{},"ISSN":["0006-291X"],"issn-type":[{"type":"print","value":"0006-291X"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Structural basis for the inhibition of the HCoV-NL63 main protease Mpro by X77","name":"articletitle","label":"Article Title"},{"value":"Biochemical and Biophysical Research Communications","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbrc.2024.150231","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"150231"}}